Plasmodium berghei Δp52&p36 parasites develop independent of a parasitophorous vacuole membrane in Huh-7 liver cells

PLoS One. 2012;7(12):e50772. doi: 10.1371/journal.pone.0050772. Epub 2012 Dec 5.

Abstract

The proteins P52 and P36 are expressed in the sporozoite stage of the murine malaria parasite Plasmodium berghei. Δp52&p36 sporozoites lacking expression of both proteins are severely compromised in their capability to develop into liver stage parasites and abort development soon after invasion; presumably due to the absence of a parasitophorous vacuole membrane (PVM). However, a small proportion of P. berghei Δp52&p36 parasites is capable to fully mature in hepatocytes causing breakthrough blood stage infections. We have studied the maturation of replicating Δp52&p36 parasites in cultured Huh-7 hepatocytes. Approximately 50% of Δp52&p36 parasites developed inside the nucleus of the hepatocyte but did not complete maturation and failed to produce merosomes. In contrast cytosolic Δp52&p36 parasites were able to fully mature and produced infectious merozoites. These Δp52&p36 parasites developed into mature schizonts in the absence of an apparent parasitophorous vacuole membrane as shown by immunofluorescence and electron microscopy. Merozoites derived from these maturing Δp52&p36 liver stages were infectious for C57BL/6 mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Nucleus / parasitology
  • Cell Nucleus / ultrastructure
  • Female
  • Hepatocytes / parasitology*
  • Hepatocytes / pathology
  • Hepatocytes / ultrastructure
  • Humans
  • Intracellular Membranes / parasitology*
  • Intracellular Membranes / ultrastructure
  • Malaria / parasitology
  • Malaria / pathology
  • Merozoites / growth & development
  • Merozoites / ultrastructure
  • Mice
  • Mice, Inbred C57BL
  • Mutant Proteins / metabolism
  • Mutation / genetics*
  • Parasites / growth & development*
  • Parasites / ultrastructure
  • Plasmodium berghei / growth & development*
  • Plasmodium berghei / ultrastructure
  • Protozoan Proteins / metabolism*
  • Vacuoles / parasitology*
  • Vacuoles / ultrastructure

Substances

  • Mutant Proteins
  • Protozoan Proteins

Grants and funding

This study was performed within the framework of Top Institute Pharma (Netherlands) project: T4-102 (www.tipharma.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.